A cautionary note on using N-acetylcysteine as an antagonist to assess isothiocyanate-induced reactive oxygen species-mediated apoptosis

Analytical Biochemistry

Volumn 405, Issue 2, 2010, Pages 269-271

  Mi, Lixin ^a   Sirajuddin, Paul ^a   Gan, Nanqin ^a   Wang, Xiantao ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CELL CULTURE; OXYGEN; REACTIVE OXYGEN SPECIES;

ANTI-OXIDANT ACTIVITIES; APOPTOSIS INDUCTION; APOPTOTIC EFFECTS; CELLULAR UPTAKE; ISOTHIOCYANATES; N-ACETYLCYSTEINE; PRE-TREATMENT; SULFORAPHANE;

CELL DEATH;

ACETYLCYSTEINE; ISOTHIOCYANIC ACID; PHENETHYL ISOTHIOCYANATE; REACTIVE OXYGEN METABOLITE; SULFORAPHANE; THIOL;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; ELECTROPHILICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 77955563428     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.06.015     Document Type: Article

References (16)

1. Morgan L.R., Holdiness M.R., Gillen L.E. N-Acetylcysteine: its bioavailability interaction with ifosfamide metabolites. Semin. Oncol. 1983, 10:56-61.
2. Kelloff G.J., Boone C.W., Crowell J.A., Steele V.E., Lubet R., Doody L.A. Surrogate endpoint biomarkers for phase II cancer chemoprevention trials. J. Cell. Biochem. Suppl. 1994, 19:1-9.
3. World Health Organization, IARC Handbook on Cancer Prevention, Vol. 9: Cruciferous Vegetables, Isothiocyanates, and Indoles, International Agency for Research on Cancer, Lyon, France, 2004.
4. Trachootham D., Zhou Y., Zhang H., Demizu Y., Chen Z., Pelicano H., Chiao P.J., Achanta G., Arlinghaus R.B., Liu J., Huang P. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate. Cancer Cell 2006, 10:241-252.
5. Kim H., Kim E.H., Eom Y.W., Kim W.H., Kwon T.K., Lee S.J., Choi K.S. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. Cancer Res. 2006, 66:1740-1750.
6. Shankar S., Ganapathy S., Srivastava R.K. Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis. Clin. Cancer Res. 2008, 14:6855-6866.
7. Singh S.V., Srivastava S.K., Choi S., Lew K.L., Antosiewicz J., Xiao D., Zeng Y., Watkins S.C., Johnson C.S., Trump D.L., Lee Y.J., Xiao H., Herman-Antosiewicz A. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J. Biol. Chem. 2005, 280:19911-19924.
8. Podhradsky D., Drobnica L., Kristian P. Reaction of cysteine, its derivatives, glutathione, coenzyme A, and dihydrolipoic acid with isothiocyanates. Experientia 1979, 35:154-155.
9. Conaway C.C., Jiao D., Kohri T., Liebes L., Chung F.L. Disposition and pharmacokinetics of phenethyl isothiocyanate and 6-phenylhexyl isothiocyanate in F344 rats. Drug Metab. Dispos. 1999, 27:13-20.
10. 14C-labelled sulforaphane. J. Labelled Compd. Radiopharm. 2003, 46:851-859.
11. Zhang Y.S., Talalay P. Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic phase 2 enzymes. Cancer Res. 1998, 58:4632-4639.
12. Mi L., Wang X., Govind S., Hood B.L., Veenstra T., Conrads T.P., Saha D.T., Goldman R., Chung F.L. The role of protein binding in induction of apoptosis by phenethyl isothiocyanate and sulforaphane in human non-small lung cancer cells. Cancer Res. 2007, 67:6409-6416.
13. Yang Y.M., Jhanwar-Uniyal M., Schwartz J., Conaway C.C., Halicka H.D., Traganos F., Chung F.L. N-Acetylcysteine conjugate of phenethyl isothiocyanate enhances apoptosis in growth-stimulated human lung cells. Cancer Res. 2005, 65:8538-8547.
14. Mi L., Xiao Z., Hood B.L., Dakshanamurthy S., Wang X., Govind S., Conrads T.P., Veenstra T.D., Chung F.L. Covalent binding to tubulin by isothiocyanates: a mechanism of cell growth arrest and apoptosis. J. Biol. Chem. 2008, 283:22136-22146.
15. Mi L., Gan N., Cheema A., Dakshanamurthy S., Wang X., Yang D.C., Chung F.L. Cancer preventive isothiocyanates induce selective degradation of cellular α- and β-tubulins by proteasomes. J. Biol. Chem. 2009, 284:17039-17051.
16. Mi L., Gan N., Chung F.L. Aggresome-like structure induced by isothiocyanates is novel proteasome-dependent degradation machinery. Biochem. Biophys. Res. Commun. 2009, 388:456-462.